Bryan Ng, PhD Student, University of Oxford, Oxford, UK, discusses the future steps of his work using human stem cells to model Alzheimer’s disease (AD). The use of tau-deficient cells to characterize cell phenotypes after treatment with amyloid beta oligomers can be expanded to analyze the mechanisms behind the observed phenotypes. For instance, a more in-depth evaluation of neuronal outgrowth impairment can be performed, and AD patient-derived stem cells can be considered for further analysis. This interview took place during the Alzheimer’s Research UK (ARUK) Conference 2021.